Details
Stereochemistry | ACHIRAL |
Molecular Formula | C29H25F4N3O5S |
Molecular Weight | 603.585 |
Optical Activity | UNSPECIFIED |
Defined Stereocenters | 3 / 3 |
E/Z Centers | 0 |
Charge | 0 |
SHOW SMILES / InChI
SMILES
OC(=O)C1=CC2=C(N=C(S2)N3[C@H]4CC[C@@H]3C[C@@H](C4)OCC5=C(ON=C5C6=CC=CC=C6OC(F)(F)F)C7CC7)C(F)=C1
InChI
InChIKey=VYLOOGHLKSNNEK-PIIMJCKOSA-N
InChI=1S/C29H25F4N3O5S/c30-21-9-15(27(37)38)10-23-25(21)34-28(42-23)36-16-7-8-17(36)12-18(11-16)39-13-20-24(35-41-26(20)14-5-6-14)19-3-1-2-4-22(19)40-29(31,32)33/h1-4,9-10,14,16-18H,5-8,11-13H2,(H,37,38)/t16-,17+,18+
Molecular Formula | C29H25F4N3O5S |
Molecular Weight | 603.585 |
Charge | 0 |
Count |
|
Stereochemistry | ABSOLUTE |
Additional Stereochemistry | No |
Defined Stereocenters | 3 / 3 |
E/Z Centers | 0 |
Optical Activity | UNSPECIFIED |
Approval Year
Cmax
Value | Dose | Co-administered | Analyte | Population |
---|---|---|---|---|
1.04 ng/mL EXPERIMENT https://pubmed.ncbi.nlm.nih.gov/36267872/ |
30 μg single, oral dose: 30 μg route of administration: Oral experiment type: SINGLE co-administered: |
TROPIFEXOR plasma | Homo sapiens population: UNHEALTHY age: ADULT sex: FEMALE / MALE food status: UNKNOWN |
|
1.25 ng/mL EXPERIMENT https://pubmed.ncbi.nlm.nih.gov/36267872/ |
30 μg 1 times / day steady-state, oral dose: 30 μg route of administration: Oral experiment type: STEADY-STATE co-administered: |
TROPIFEXOR plasma | Homo sapiens population: UNHEALTHY age: ADULT sex: FEMALE / MALE food status: UNKNOWN |
|
1.8 ng/mL EXPERIMENT https://pubmed.ncbi.nlm.nih.gov/36267872/ |
60 μg single, oral dose: 60 μg route of administration: Oral experiment type: SINGLE co-administered: |
TROPIFEXOR plasma | Homo sapiens population: UNHEALTHY age: ADULT sex: FEMALE / MALE food status: UNKNOWN |
|
2.55 ng/mL EXPERIMENT https://pubmed.ncbi.nlm.nih.gov/36267872/ |
60 μg 1 times / day steady-state, oral dose: 60 μg route of administration: Oral experiment type: STEADY-STATE co-administered: |
TROPIFEXOR plasma | Homo sapiens population: UNHEALTHY age: ADULT sex: FEMALE / MALE food status: UNKNOWN |
|
2.37 ng/mL EXPERIMENT https://pubmed.ncbi.nlm.nih.gov/36267872/ |
90 μg single, oral dose: 90 μg route of administration: Oral experiment type: SINGLE co-administered: |
TROPIFEXOR plasma | Homo sapiens population: UNHEALTHY age: ADULT sex: FEMALE / MALE food status: UNKNOWN |
|
4.3 ng/mL EXPERIMENT https://pubmed.ncbi.nlm.nih.gov/36267872/ |
90 μg 1 times / day steady-state, oral dose: 90 μg route of administration: Oral experiment type: STEADY-STATE co-administered: |
TROPIFEXOR plasma | Homo sapiens population: UNHEALTHY age: ADULT sex: FEMALE / MALE food status: UNKNOWN |
|
4.84 ng/mL EXPERIMENT https://pubmed.ncbi.nlm.nih.gov/36267872/ |
150 μg single, oral dose: 150 μg route of administration: Oral experiment type: SINGLE co-administered: |
TROPIFEXOR plasma | Homo sapiens population: UNHEALTHY age: ADULT sex: FEMALE / MALE food status: UNKNOWN |
|
6.37 ng/mL EXPERIMENT https://pubmed.ncbi.nlm.nih.gov/36267872/ |
150 μg 1 times / day steady-state, oral dose: 150 μg route of administration: Oral experiment type: STEADY-STATE co-administered: |
TROPIFEXOR plasma | Homo sapiens population: UNHEALTHY age: ADULT sex: FEMALE / MALE food status: UNKNOWN |
|
0.19 ng/mL EXPERIMENT https://pubmed.ncbi.nlm.nih.gov/36267872/ |
10 μg single, oral dose: 10 μg route of administration: Oral experiment type: SINGLE co-administered: |
TROPIFEXOR plasma | Homo sapiens population: HEALTHY age: ADULT sex: FEMALE / MALE food status: FASTED |
|
0.63 ng/mL EXPERIMENT https://pubmed.ncbi.nlm.nih.gov/36267872/ |
30 μg single, oral dose: 30 μg route of administration: Oral experiment type: SINGLE co-administered: |
TROPIFEXOR plasma | Homo sapiens population: HEALTHY age: ADULT sex: FEMALE / MALE food status: FASTED |
|
1.7 ng/mL EXPERIMENT https://pubmed.ncbi.nlm.nih.gov/36267872/ |
100 μg single, oral dose: 100 μg route of administration: Oral experiment type: SINGLE co-administered: |
TROPIFEXOR plasma | Homo sapiens population: HEALTHY age: ADULT sex: FEMALE / MALE food status: FASTED |
|
6.4 ng/mL EXPERIMENT https://pubmed.ncbi.nlm.nih.gov/36267872/ |
300 μg single, oral dose: 300 μg route of administration: Oral experiment type: SINGLE co-administered: |
TROPIFEXOR plasma | Homo sapiens population: HEALTHY age: ADULT sex: FEMALE / MALE food status: FASTED |
|
10.4 ng/mL EXPERIMENT https://pubmed.ncbi.nlm.nih.gov/36267872/ |
300 μg single, oral dose: 300 μg route of administration: Oral experiment type: SINGLE co-administered: |
TROPIFEXOR plasma | Homo sapiens population: HEALTHY age: ADULT sex: FEMALE / MALE food status: FED |
|
22.1 ng/mL EXPERIMENT https://pubmed.ncbi.nlm.nih.gov/36267872/ |
1000 μg single, oral dose: 1000 μg route of administration: Oral experiment type: SINGLE co-administered: |
TROPIFEXOR plasma | Homo sapiens population: HEALTHY age: ADULT sex: FEMALE / MALE food status: FASTED |
|
54.2 ng/mL EXPERIMENT https://pubmed.ncbi.nlm.nih.gov/36267872/ |
3000 μg single, oral dose: 3000 μg route of administration: Oral experiment type: SINGLE co-administered: |
TROPIFEXOR plasma | Homo sapiens population: HEALTHY age: ADULT sex: FEMALE / MALE food status: FASTED |
|
3.42 ng/mL |
200 μg single, oral dose: 200 μg route of administration: Oral experiment type: SINGLE co-administered: |
TROPIFEXOR plasma | Homo sapiens population: HEALTHY age: ADULT sex: FEMALE / MALE food status: FASTED |
AUC
Value | Dose | Co-administered | Analyte | Population |
---|---|---|---|---|
4.98 ng × h/mL EXPERIMENT https://pubmed.ncbi.nlm.nih.gov/36267872/ |
30 μg single, oral dose: 30 μg route of administration: Oral experiment type: SINGLE co-administered: |
TROPIFEXOR plasma | Homo sapiens population: UNHEALTHY age: ADULT sex: FEMALE / MALE food status: UNKNOWN |
|
7.95 ng × h/mL EXPERIMENT https://pubmed.ncbi.nlm.nih.gov/36267872/ |
30 μg 1 times / day steady-state, oral dose: 30 μg route of administration: Oral experiment type: STEADY-STATE co-administered: |
TROPIFEXOR plasma | Homo sapiens population: UNHEALTHY age: ADULT sex: FEMALE / MALE food status: UNKNOWN |
|
12.1 ng × h/mL EXPERIMENT https://pubmed.ncbi.nlm.nih.gov/36267872/ |
60 μg single, oral dose: 60 μg route of administration: Oral experiment type: SINGLE co-administered: |
TROPIFEXOR plasma | Homo sapiens population: UNHEALTHY age: ADULT sex: FEMALE / MALE food status: UNKNOWN |
|
17.6 ng × h/mL EXPERIMENT https://pubmed.ncbi.nlm.nih.gov/36267872/ |
60 μg 1 times / day steady-state, oral dose: 60 μg route of administration: Oral experiment type: STEADY-STATE co-administered: |
TROPIFEXOR plasma | Homo sapiens population: UNHEALTHY age: ADULT sex: FEMALE / MALE food status: UNKNOWN |
|
23.4 ng × h/mL EXPERIMENT https://pubmed.ncbi.nlm.nih.gov/36267872/ |
90 μg 1 times / day steady-state, oral dose: 90 μg route of administration: Oral experiment type: STEADY-STATE co-administered: |
TROPIFEXOR plasma | Homo sapiens population: UNHEALTHY age: ADULT sex: FEMALE / MALE food status: UNKNOWN |
|
24.5 ng × h/mL EXPERIMENT https://pubmed.ncbi.nlm.nih.gov/36267872/ |
150 μg single, oral dose: 150 μg route of administration: Oral experiment type: SINGLE co-administered: |
TROPIFEXOR plasma | Homo sapiens population: UNHEALTHY age: ADULT sex: FEMALE / MALE food status: UNKNOWN |
|
44.2 ng × h/mL EXPERIMENT https://pubmed.ncbi.nlm.nih.gov/36267872/ |
150 μg 1 times / day steady-state, oral dose: 150 μg route of administration: Oral experiment type: STEADY-STATE co-administered: |
TROPIFEXOR plasma | Homo sapiens population: UNHEALTHY age: ADULT sex: FEMALE / MALE food status: UNKNOWN |
|
3.39 ng × h/mL EXPERIMENT https://pubmed.ncbi.nlm.nih.gov/36267872/ |
10 μg single, oral dose: 10 μg route of administration: Oral experiment type: SINGLE co-administered: |
TROPIFEXOR plasma | Homo sapiens population: HEALTHY age: ADULT sex: FEMALE / MALE food status: FASTED |
|
13.4 ng × h/mL EXPERIMENT https://pubmed.ncbi.nlm.nih.gov/36267872/ |
30 μg single, oral dose: 30 μg route of administration: Oral experiment type: SINGLE co-administered: |
TROPIFEXOR plasma | Homo sapiens population: HEALTHY age: ADULT sex: FEMALE / MALE food status: FASTED |
|
37.9 ng × h/mL EXPERIMENT https://pubmed.ncbi.nlm.nih.gov/36267872/ |
100 μg single, oral dose: 100 μg route of administration: Oral experiment type: SINGLE co-administered: |
TROPIFEXOR plasma | Homo sapiens population: HEALTHY age: ADULT sex: FEMALE / MALE food status: FASTED |
|
123 ng × h/mL EXPERIMENT https://pubmed.ncbi.nlm.nih.gov/36267872/ |
300 μg single, oral dose: 300 μg route of administration: Oral experiment type: SINGLE co-administered: |
TROPIFEXOR plasma | Homo sapiens population: HEALTHY age: ADULT sex: FEMALE / MALE food status: FASTED |
|
203 ng × h/mL EXPERIMENT https://pubmed.ncbi.nlm.nih.gov/36267872/ |
300 μg single, oral dose: 300 μg route of administration: Oral experiment type: SINGLE co-administered: |
TROPIFEXOR plasma | Homo sapiens population: HEALTHY age: ADULT sex: FEMALE / MALE food status: FED |
|
482 ng × h/mL EXPERIMENT https://pubmed.ncbi.nlm.nih.gov/36267872/ |
1000 μg single, oral dose: 1000 μg route of administration: Oral experiment type: SINGLE co-administered: |
TROPIFEXOR plasma | Homo sapiens population: HEALTHY age: ADULT sex: FEMALE / MALE food status: FASTED |
|
933 ng × h/mL EXPERIMENT https://pubmed.ncbi.nlm.nih.gov/36267872/ |
3000 μg single, oral dose: 3000 μg route of administration: Oral experiment type: SINGLE co-administered: |
TROPIFEXOR plasma | Homo sapiens population: HEALTHY age: ADULT sex: FEMALE / MALE food status: FASTED |
|
73.8 ng × h/mL |
200 μg single, oral dose: 200 μg route of administration: Oral experiment type: SINGLE co-administered: |
TROPIFEXOR plasma | Homo sapiens population: HEALTHY age: ADULT sex: FEMALE / MALE food status: FASTED |
T1/2
Value | Dose | Co-administered | Analyte | Population |
---|---|---|---|---|
14.9 h EXPERIMENT https://pubmed.ncbi.nlm.nih.gov/36267872/ |
10 μg single, oral dose: 10 μg route of administration: Oral experiment type: SINGLE co-administered: |
TROPIFEXOR plasma | Homo sapiens population: HEALTHY age: ADULT sex: FEMALE / MALE food status: FASTED |
|
13.7 h EXPERIMENT https://pubmed.ncbi.nlm.nih.gov/36267872/ |
30 μg single, oral dose: 30 μg route of administration: Oral experiment type: SINGLE co-administered: |
TROPIFEXOR plasma | Homo sapiens population: HEALTHY age: ADULT sex: FEMALE / MALE food status: FASTED |
|
13.5 h EXPERIMENT https://pubmed.ncbi.nlm.nih.gov/36267872/ |
100 μg single, oral dose: 100 μg route of administration: Oral experiment type: SINGLE co-administered: |
TROPIFEXOR plasma | Homo sapiens population: HEALTHY age: ADULT sex: FEMALE / MALE food status: FASTED |
|
15.3 h EXPERIMENT https://pubmed.ncbi.nlm.nih.gov/36267872/ |
300 μg single, oral dose: 300 μg route of administration: Oral experiment type: SINGLE co-administered: |
TROPIFEXOR plasma | Homo sapiens population: HEALTHY age: ADULT sex: FEMALE / MALE food status: FASTED |
|
12 h EXPERIMENT https://pubmed.ncbi.nlm.nih.gov/36267872/ |
300 μg single, oral dose: 300 μg route of administration: Oral experiment type: SINGLE co-administered: |
TROPIFEXOR plasma | Homo sapiens population: HEALTHY age: ADULT sex: FEMALE / MALE food status: FED |
|
21.9 h EXPERIMENT https://pubmed.ncbi.nlm.nih.gov/36267872/ |
1000 μg single, oral dose: 1000 μg route of administration: Oral experiment type: SINGLE co-administered: |
TROPIFEXOR plasma | Homo sapiens population: HEALTHY age: ADULT sex: FEMALE / MALE food status: FASTED |
|
16.5 h EXPERIMENT https://pubmed.ncbi.nlm.nih.gov/36267872/ |
3000 μg single, oral dose: 3000 μg route of administration: Oral experiment type: SINGLE co-administered: |
TROPIFEXOR plasma | Homo sapiens population: HEALTHY age: ADULT sex: FEMALE / MALE food status: FASTED |
Funbound
Value | Dose | Co-administered | Analyte | Population |
---|---|---|---|---|
0.13% |
200 μg single, oral dose: 200 μg route of administration: Oral experiment type: SINGLE co-administered: |
TROPIFEXOR plasma | Homo sapiens population: HEALTHY age: ADULT sex: FEMALE / MALE food status: FASTED |
Substance Class |
Chemical
Created
by
admin
on
Edited
Mon Mar 31 22:09:47 GMT 2025
by
admin
on
Mon Mar 31 22:09:47 GMT 2025
|
Record UNII |
NMZ08KM76Z
|
Record Status |
Validated (UNII)
|
Record Version |
|
-
Download
Name | Type | Language | ||
---|---|---|---|---|
|
Official Name | English | ||
|
Preferred Name | English | ||
|
Code | English | ||
|
Code | English | ||
|
Systematic Name | English | ||
|
Common Name | English | ||
|
Code | English | ||
|
Systematic Name | English | ||
|
Common Name | English |
Classification Tree | Code System | Code | ||
---|---|---|---|---|
|
NCI_THESAURUS |
C78276
Created by
admin on Mon Mar 31 22:09:47 GMT 2025 , Edited by admin on Mon Mar 31 22:09:47 GMT 2025
|
||
|
NCI_THESAURUS |
C2081
Created by
admin on Mon Mar 31 22:09:47 GMT 2025 , Edited by admin on Mon Mar 31 22:09:47 GMT 2025
|
Code System | Code | Type | Description | ||
---|---|---|---|---|---|
|
C152764
Created by
admin on Mon Mar 31 22:09:47 GMT 2025 , Edited by admin on Mon Mar 31 22:09:47 GMT 2025
|
PRIMARY | |||
|
100000176172
Created by
admin on Mon Mar 31 22:09:47 GMT 2025 , Edited by admin on Mon Mar 31 22:09:47 GMT 2025
|
PRIMARY | |||
|
NMZ08KM76Z
Created by
admin on Mon Mar 31 22:09:47 GMT 2025 , Edited by admin on Mon Mar 31 22:09:47 GMT 2025
|
PRIMARY | |||
|
121418176
Created by
admin on Mon Mar 31 22:09:47 GMT 2025 , Edited by admin on Mon Mar 31 22:09:47 GMT 2025
|
PRIMARY | |||
|
10443
Created by
admin on Mon Mar 31 22:09:47 GMT 2025 , Edited by admin on Mon Mar 31 22:09:47 GMT 2025
|
PRIMARY | |||
|
GH-47
Created by
admin on Mon Mar 31 22:09:47 GMT 2025 , Edited by admin on Mon Mar 31 22:09:47 GMT 2025
|
PRIMARY | |||
|
1383819-10-0
Created by
admin on Mon Mar 31 22:09:47 GMT 2025 , Edited by admin on Mon Mar 31 22:09:47 GMT 2025
|
NON-SPECIFIC STEREOCHEMISTRY | |||
|
1383816-29-2
Created by
admin on Mon Mar 31 22:09:47 GMT 2025 , Edited by admin on Mon Mar 31 22:09:47 GMT 2025
|
PRIMARY | |||
|
DTXSID001100225
Created by
admin on Mon Mar 31 22:09:47 GMT 2025 , Edited by admin on Mon Mar 31 22:09:47 GMT 2025
|
PRIMARY | |||
|
Tropifexor
Created by
admin on Mon Mar 31 22:09:47 GMT 2025 , Edited by admin on Mon Mar 31 22:09:47 GMT 2025
|
PRIMARY |
Related Record | Type | Details | ||
---|---|---|---|---|
|
TARGET -> AGONIST |
EC50
|
Related Record | Type | Details | ||
---|---|---|---|---|
|
ACTIVE MOIETY |